Back to results
US 2010/0144806 A1Published application
Cyclopropanecarboxylic Acid Compound
AssigneeTakeda Pharmaceutical Company Limited
InventorsTsuneo Yasuma, Nobuyuki Negoro
Life of this patent
Estimating the term…
Abstract
A compound of the formula (I): wherein each symbol is as defined in the description, a salt s thereof, and a prodrug thereof of the present invention unexpectedly have a superior GPR40 receptor agonist activity and superior properties as pharmaceutical products such as stability and the like, and can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor-related pathology or diseases in mammals.
Claims19
A compound represented by the formula:
- wherein
- ring A is an optionally substituted cyclic group;
- ring B is an optionally substituted ring;
- V is a bond or a spacer having 1 to 3 atoms in the main chain;
- W is an optionally substituted C1-6 alkylene group;
- X is O or S;
- R1 and R2 are the same or different and each is a hydrogen atom, a halogen atom, a C1-6 alkyl group or a C1-6 alkoxy group;
- and
- R3 is an optionally substituted hydroxy group or an optionally substituted amino group,
- provided that when V is a bond and W is a methylene group, then ring B should not be oxazole and thiazole,
- or a salt thereof, excluding 2-(2-{[6-(benzyloxy)-2-naphthyl]methoxy}phenyl)cyclopropanecarboxylic acid.
8 more elements
(canceled)
(canceled)
Dependencies are inferred from the claim text.